Shandong Lukang Pharmaceutical Co Ltd (600789) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.002x

Based on the latest financial reports, Shandong Lukang Pharmaceutical Co Ltd (600789) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.39 Million ≈ $-935.75K USD) by net assets (CN¥4.10 Billion ≈ $600.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Shandong Lukang Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Shandong Lukang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shandong Lukang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Lukang Pharmaceutical Co Ltd (600789) stock price for real-time trading data and today's change.

Shandong Lukang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Lukang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review 600789 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Beijing Lier High Temperature Materials Co Ltd
SHE:002392
0.010x
Sinofibers Technology Co Ltd
SHE:300777
-0.022x
Amalgamated Bank
NASDAQ:AMAL
0.070x
Utz Brands Inc
NYSE:UTZ
0.000x
Pagaya Technologies Ltd.
NASDAQ:PGY
0.072x
Ziel Home Furnishing Technology Co. Ltd. A
SHE:301376
N/A
Zillow Group Inc
NASDAQ:ZG
0.045x
Lotte Rental Co Ltd
KO:089860
-0.077x

Annual Cash Flow Conversion Efficiency for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Lukang Pharmaceutical Co Ltd from 1998 to 2025. Also see how large is Shandong Lukang Pharmaceutical Co Ltd's balance sheet for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.26 Billion
≈ $769.21 Million
CN¥698.17 Million
≈ $102.16 Million
0.133x +33.92%
2024-12-31 CN¥4.06 Billion
≈ $594.34 Million
CN¥402.82 Million
≈ $58.94 Million
0.099x -38.57%
2023-12-31 CN¥3.74 Billion
≈ $547.48 Million
CN¥604.01 Million
≈ $88.39 Million
0.161x +27.41%
2022-12-31 CN¥3.51 Billion
≈ $513.21 Million
CN¥444.38 Million
≈ $65.03 Million
0.127x +188.43%
2021-12-31 CN¥3.40 Billion
≈ $497.41 Million
CN¥149.33 Million
≈ $21.85 Million
0.044x -37.08%
2020-12-31 CN¥3.36 Billion
≈ $491.57 Million
CN¥234.55 Million
≈ $34.32 Million
0.070x -38.80%
2019-12-31 CN¥3.17 Billion
≈ $464.11 Million
CN¥361.87 Million
≈ $52.95 Million
0.114x -0.18%
2018-12-31 CN¥3.07 Billion
≈ $449.48 Million
CN¥351.09 Million
≈ $51.37 Million
0.114x -12.93%
2017-12-31 CN¥2.10 Billion
≈ $307.12 Million
CN¥275.51 Million
≈ $40.32 Million
0.131x -12.17%
2016-12-31 CN¥1.98 Billion
≈ $290.03 Million
CN¥296.23 Million
≈ $43.35 Million
0.149x +263.29%
2015-12-31 CN¥1.91 Billion
≈ $278.80 Million
CN¥78.39 Million
≈ $11.47 Million
0.041x -43.00%
2014-12-31 CN¥1.50 Billion
≈ $220.11 Million
CN¥108.56 Million
≈ $15.89 Million
0.072x -54.00%
2013-12-31 CN¥1.63 Billion
≈ $239.22 Million
CN¥256.50 Million
≈ $37.53 Million
0.157x +118.86%
2012-12-31 CN¥1.61 Billion
≈ $235.15 Million
CN¥115.20 Million
≈ $16.86 Million
0.072x -1.52%
2011-12-31 CN¥1.69 Billion
≈ $247.82 Million
CN¥123.28 Million
≈ $18.04 Million
0.073x -60.49%
2010-12-31 CN¥1.68 Billion
≈ $245.35 Million
CN¥308.88 Million
≈ $45.20 Million
0.184x +42.96%
2009-12-31 CN¥1.55 Billion
≈ $226.53 Million
CN¥199.49 Million
≈ $29.19 Million
0.129x -7.63%
2008-12-31 CN¥1.50 Billion
≈ $219.63 Million
CN¥209.39 Million
≈ $30.64 Million
0.140x +48.39%
2007-12-31 CN¥1.46 Billion
≈ $213.69 Million
CN¥137.30 Million
≈ $20.09 Million
0.094x +137.70%
2006-12-31 CN¥1.42 Billion
≈ $208.09 Million
CN¥56.24 Million
≈ $8.23 Million
0.040x -63.33%
2005-12-31 CN¥1.50 Billion
≈ $219.27 Million
CN¥161.64 Million
≈ $23.65 Million
0.108x +155.06%
2004-12-31 CN¥1.50 Billion
≈ $218.82 Million
CN¥63.24 Million
≈ $9.25 Million
0.042x -59.21%
2003-12-31 CN¥1.61 Billion
≈ $236.31 Million
CN¥167.42 Million
≈ $24.50 Million
0.104x -58.61%
2002-12-31 CN¥1.26 Billion
≈ $184.36 Million
CN¥315.59 Million
≈ $46.18 Million
0.250x +7.61%
2001-12-31 CN¥1.16 Billion
≈ $170.00 Million
CN¥270.43 Million
≈ $39.57 Million
0.233x +1077.05%
2000-12-31 CN¥1.13 Billion
≈ $165.42 Million
CN¥22.36 Million
≈ $3.27 Million
0.020x -38.07%
1999-12-31 CN¥1.10 Billion
≈ $160.95 Million
CN¥35.12 Million
≈ $5.14 Million
0.032x -22.53%
1998-12-31 CN¥1.12 Billion
≈ $163.93 Million
CN¥46.18 Million
≈ $6.76 Million
0.041x --

About Shandong Lukang Pharmaceutical Co Ltd

SHG:600789 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.27 Billion
CN¥8.65 Billion CNY
Market Cap Rank
#7861 Global
#1771 in China
Share Price
CN¥8.28
Change (1 day)
+1.60%
52-Week Range
CN¥6.76 - CN¥10.71
All Time High
CN¥16.22
About

Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products. It offers human and veterinary active pharmaceutical ingredient; veterinary formulation; bio-pesticides; and amino acid. The company also exports its produ… Read more